{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:36:49Z","timestamp":1783633009957,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clon.2024.103686","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T23:33:59Z","timestamp":1731108839000},"page":"103686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Long-term Clinical Outcomes of Patients With Medullary Thyroid Cancer: A Single Institution, Tertiary Referral Centre Experience"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4039-3921","authenticated-orcid":false,"given":"K.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8726-7784","authenticated-orcid":false,"given":"S.","family":"Forner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Johri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1565-8617","authenticated-orcid":false,"given":"D.","family":"Morganstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Newbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2024.103686_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nrendo.2016.110","article-title":"The changing incidence of thyroid cancer","volume":"12","author":"Kitahara","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.clon.2024.103686_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974\u20132013","author":"Lim","year":"2017","journal-title":"JAMA [Internet]"},{"key":"10.1016\/j.clon.2024.103686_bib3","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2011.35.5040","article-title":"Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial","author":"Wells","year":"2012","journal-title":"J Clin Oncol [Internet]"},{"key":"10.1016\/j.clon.2024.103686_bib4","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2012.48.4659","article-title":"Cabozantinib in Progressive Medullary Thyroid Cancer","author":"Elisei","year":"2013","journal-title":"J Clin Oncol [Internet]"},{"issue":"9","key":"10.1016\/j.clon.2024.103686_bib5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa2005651","article-title":"Efficacy of Selpercatinib in RET -Altered Thyroid Cancers","volume":"383","author":"Wirth","year":"2020","journal-title":"New Engl J Med"},{"issue":"20","key":"10.1016\/j.clon.2024.103686_bib6","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa2309719","article-title":"Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer","volume":"389","author":"Hadoux","year":"2023","journal-title":"New Engl J Med [Internet]"},{"issue":"8","key":"10.1016\/j.clon.2024.103686_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S2213-8587(21)00120-0","article-title":"Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1\/2 study","volume":"9","author":"Subbiah","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.clon.2024.103686_bib8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0748-7983(96)92294-5","article-title":"Medullary thyroid cancer: the role of radiotherapy in local control","volume":"22","author":"Fife","year":"1996","journal-title":"Eur J Surg Oncol [Internet]"},{"issue":"7","key":"10.1016\/j.clon.2024.103686_bib9","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1053\/ejso.2000.0981","article-title":"Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival","volume":"26","author":"Hyer","year":"2000","journal-title":"Eur J Surg Oncol (EJSO)"},{"key":"10.1016\/j.clon.2024.103686_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.22244","article-title":"Prognosis of medullary thyroid carcinoma","author":"Roman","year":"2006","journal-title":"Cancer [Internet]"},{"key":"10.1016\/j.clon.2024.103686_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13044-017-0041-6","article-title":"A\u00a0retrospective review of the multidisciplinary management of medullary thyroid cancer: eligibility for systemic therapy","volume":"10","author":"Geller","year":"2017","journal-title":"Thyroid Res"},{"key":"10.1016\/j.clon.2024.103686_bib12","series-title":"RET inhibitor refractory patients with RET-altered cancers (trial in progress). [Internet]","article-title":"A\u00a0first-in-human phase 1 study of the next-generation RET inhibitor, LOXO-260","author":"Pennell","year":"2022"},{"key":"10.1016\/j.clon.2024.103686_bib15","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.20.02903","article-title":"Tipifarnib in head and neck squamous cell carcinoma with HRAS mutations","author":"Ho","year":"2021","journal-title":"J Clin Oncol [Internet]"},{"key":"10.1016\/j.clon.2024.103686_bib16","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2009-2368","article-title":"Biomarker-Based Risk Stratification for Previously Untreated Medullary Thyroid Cancer","author":"Machens","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab [Internet]"},{"issue":"12","key":"10.1016\/j.clon.2024.103686_bib17","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2024.103686_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/00000658-199906000-00016","article-title":"Patterns of Nodal Metastases in Palpable Medullary Thyroid Carcinoma: Recommendations for Extent of Node Dissection","author":"Moley","year":"1999","journal-title":"Ann Surg [Internet]"},{"issue":"6","key":"10.1016\/j.clon.2024.103686_bib19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American thyroid association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.clon.2024.103686_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/0194599820947696","article-title":"External Beam Radiotherapy for Medullary Thyroid Cancer Following Total or Near-Total Thyroidectomy","author":"Jin","year":"2021","journal-title":"Otolaryngol Head Neck Surg [Internet]"},{"key":"10.1016\/j.clon.2024.103686_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/hed.20791","article-title":"Postoperative radiotherapy for advanced medullary thyroid cancer\u2014Local disease control in the modern era","author":"Schwartz","year":"2008","journal-title":"Head Neck [Internet]"},{"key":"10.1016\/j.clon.2024.103686_bib22","doi-asserted-by":"crossref","DOI":"10.4158\/ACCR-2017-0082","article-title":"Development of Upper Aerodigestive Tract Complications in Patients with Stage IV Thyroid Cancer Receiving Tyrosine Kinase Inhibitors","author":"Perdoni","year":"2018","journal-title":"AACE Clin Case Rep [Internet]"},{"key":"10.1016\/j.clon.2024.103686_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx479","article-title":"Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma","author":"Schlumberger","year":"2017","journal-title":"Ann Oncol [Internet]"},{"key":"10.1016\/j.clon.2024.103686_bib24","series-title":"Restriction of indication","year":"2023"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655524004825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655524004825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T20:36:44Z","timestamp":1737319004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655524004825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":22,"alternative-id":["S0936655524004825"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2024.103686","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Clinical Outcomes of Patients With Medullary Thyroid Cancer: A Single Institution, Tertiary Referral Centre Experience","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2024.103686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Ltd on behalf of The Royal College of Radiologists. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103686"}}